Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity

American Journal of Preventive Medicine

Volumn 51, Issue 4, 2016, Pages 507-512

  McCarthy, Anne Marie ^a   Kim, Jane J ^b   Beaber, Elisabeth F ^c   Zheng, Yingye ^c   Burnett Hartman, Andrea ^c,d   Chubak, Jessica ^e   Ghai, Nirupa R ^d   McLerran, Dale ^c   Breen, Nancy ^f   Conant, Emily F ^g   Geller, Berta M ^h   Green, Beverly B ^e   Klabunde, Carrie N ⁱ   Inrig, Stephen ^j,k   Skinner, Celette Sugg ^l   Quinn, Virginia P ^d   Haas, Jennifer S ^m   Schnall, Mitchell ^g   Rutter, Carolyn M ⁿ   Barlow, William E ^o   Corley, Douglas A ^d   Armstrong, Katrina ^a   Doubeni, Chyke A ^g   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d KAISER PERMANENTE   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

ⁱ NATIONAL INSTITUTES OF HEALTH   (United States)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k MOUNT SAINT MARY'S UNIVERSITY   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁿ RAND CORPORATION   (United States)

^o UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; ETHNICITY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OCCULT BLOOD TEST; AFTERCARE; BREAST TUMOR; COLORECTAL TUMOR; ETHNOLOGY; FEMALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; STATISTICS AND NUMERICAL DATA;

ADULT; AFTERCARE; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD;

EID: 84964587044     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2016.03.017     Document Type: Article

References (32)

1. 1 Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149:9 (2008), 627–637, 10.7326/0003-4819-149-9-200811040-00243.
2. 2 Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 151:10 (2009), 716–726, 10.7326/0003-4819-151-10-200911170-00008.
3. 3 Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:3 (2008), 130–160, 10.3322/CA.2007.0018.
4. 4 Smith, R.A., Manassaram-Baptiste, D., Brooks, D., et al. Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 65:1 (2015), 30–54, 10.3322/caac.21261.
5. 5 Yabroff, K.R., Washington, K.S., Leader, A., Neilson, E., Mandelblatt, J., Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev 60:3 (2003), 294–331, 10.1177/1077558703254698.
6. 6 Zapka, J., Taplin, S.H., Price, R.A., Cranos, C., Yabroff, R., Factors in quality care—the case of follow-up to abnormal cancer screening tests—problems in the steps and interfaces of care. J Natl Cancer Inst Monogr 2010:40 (2010), 58–71, 10.1093/jncimonographs/lgq009.
7. 7 Wujcik, D., Shyr, Y., Li, M., et al. Delay in diagnostic testing after abnormal mammography in low-income women. Oncol Nurs Forum 36:6 (2009), 709–715, 10.1188/09.ONF.709-715.
8. 8 Jones, B.A., Dailey, A., Calvocoressi, L., et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Causes Control 16:7 (2005), 809–821, 10.1007/s10552-005-2905-7.
9. 9 Gorin, S.S., Heck, J.E., Cheng, B., Smith, S.J., Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:20 (2006), 2244–2252, 10.1001/archinte.166.20.2244.
10. 10 Perez-Stable, E.J., Afable-Munsuz, A., Kaplan, C.P., et al. Factors influencing time to diagnosis after abnormal mammography in diverse women. J Womens Health (Larchmt) 22:2 (2013), 159–166, 10.1089/jwh.2012.3646.
11. 11 Warner, E.T., Tamimi, R.M., Hughes, M.E., et al. Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat 136:3 (2012), 813–821, 10.1007/s10549-012-2304-1.
12. 12 Wujcik, D., Fair, A.M., Barriers to diagnostic resolution after abnormal mammography: a review of the literature. Cancer Nurs 31:5 (2008), E16–E30, 10.1097/01.NCC.0000305764.96732.45.
13. 13 Ramirez, A.G., Perez-Stable, E.J., Talavera, G.A., et al. Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the Six Cities Study. Springerplus, 2(1), 2013, 84, 10.1186/2193-1801-2-84.
14. 14 Battaglia, T.A., Santana, M.C., Bak, S., et al. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers. Cancer 116:4 (2010), 913–921, 10.1002/cncr.24851.
15. 15 Mojica, C.M., Bastani, R., Ponce, N.A., Boscardin, W.J., Latinas with abnormal breast findings: patient predictors of timely diagnostic resolution. J Womens Health (Larchmt) 16:10 (2007), 1468–1477, 10.1089/jwh.2006.0324.
16. 16 Kaplan, C.P., Crane, L.A., Stewart, S., Juarez-Reyes, M., Factors affecting follow-up among low-income women with breast abnormalities. J Womens Health (Larchmt) 13:2 (2004), 195–206, 10.1089/154099904322966182.
17. 17 Partin, M.R., Gravely, A., Gellad, Z.F., et al. Factors associated with missed and cancelled colonoscopy appointments at Veterans Health Administration facilities. Clin Gastroenterol Hepatol 14:2 (2016), 259–267, 10.1016/j.cgh.2015.07.051.
18. 18 Tosteson, A.N., Beaber, E.F., Tiro, J., et al. Variation in screening abnormality rates and follow-up of breast, cervical and colorectal cancer screening within the PROSPR consortium. J Gen Intern Med 31:4 (2016), 372–379.
19. 19 Beaber, E.F., Kim, J.J., Schapira, M.M., et al. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst, 107(6), 2015, djv120, 10.1093/jnci/djv120.
20. 20 Tiro, J.A., Kamineni, A., Levin, T.R., et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev 23:7 (2014), 1147–1158, 10.1158/1055-9965.EPI-13-1217.
21. 21 American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS). 4th ed., 2003, American College of Radiology, Reston, VA.
22. 22 Miglioretti, D.L., Rutter, C.M., Bradford, S.C., et al. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care 46:9)(suppl 1 (2008), S91–S96, 10.1097/MLR.0b013e31817946c8.
23. 23 Green, B.B., Anderson, M.L., Wang, C.Y., et al. Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med 27:6 (2014), 789–795, 10.3122/jabfm.2014.06.140125.
24. 24 Fisher, D.A., Jeffreys, A., Coffman, C.J., Fasanella, K., Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev 15:6 (2006), 1232–1235, 10.1158/1055-9965.EPI-05-0916.
25. 25 Etzioni, D.A., Yano, E.M., Rubenstein, L.V., et al. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum 49:7 (2006), 1002–1010, 10.1007/s10350-006-0533-2.
26. 26 Garman, K.S., Jeffreys, A., Coffman, C., Fisher, D.A., Colorectal cancer screening, comorbidity, and follow-up in elderly patients. Am J Med Sci 332:4 (2006), 159–163, 10.1097/00000441-200610000-00001.
27. 27 Partin, M.R., Burgess, D.J., Burgess, J.F. Jr., et al. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study. Cancer Epidemiol Biomarkers Prev 24:2 (2015), 422–434, 10.1158/1055-9965.EPI-14-1170.
28. 28 Partin, M.R., Powell, A.A., Nugent, S., Ordin, D.L., Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals. J Healthc Qual 35:3 (2013), 41–48, 10.1111/j.1945-1474.2011.00188.x.
29. 29 Linver, M.N., Osuch, J.R., Brenner, R.J., Smith, R.A., The mammography audit: a primer for the mammography quality standards act (MQSA). Am J Roentgenol 165:1 (1995), 19–25, 10.2214/ajr.165.1.7785586.
30. 30 Green, B.B., Coronado, G.D., Devoe, J.E., Allison, J., Navigating the murky waters of colorectal cancer screening and health reform. Am J Public Health 104:6 (2014), 982–986, 10.2105/AJPH.2014.301877.
31. 31 Doubeni, C.A., The impact of colorectal cancer screening on the U.S. population: is it time to celebrate?. Cancer 120:18 (2014), 2810–2813, 10.1002/cncr.28789.
32. 32 Levin, T.R., Jamieson, L., Burley, D.A., Reyes, J., Oehrli, M., Caldwell, C., Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 33:1 (2011), 101–110, 10.1093/epirev/mxr007.